The company, based in Espoo, Finland, currently operates these divisions as distinct segments with independent growth trajectories. The recent acquisition of Severn, which pushed the Process Performance Solutions segment to approximately 1.7 billion euros in annual net sales, served as a catalyst for the board to assess whether a separation could provide the agility and management focus needed for each unit to reach its full potential.
Biomaterial Solutions and Services maintains a strong market position anchored in pulp, paper, and energy sectors. Conversely, the Process Performance Solutions unit has evolved into a diversified industrial platform, with nearly 70 percent of its revenue now originating outside the traditional pulp and paper industries. Board Chair Pekka Vauramo stated that the review will only result in a transaction if the analysis confirms that independent operations serve the best interests of shareholders. CEO Thomas Hinnerskov emphasized that while the review is underway, the company remains committed to its current strategy and customer service standards.




Comments (0)
No comments yet. Be the first!